Why choose a biosimilar?

Biosimilars - why choose them?

Biosimilars facilitate patient access, provide more affordable treatment options and encourage innovation.1,2

Lower cost
The development of biosimilars can create lower patient costs for treatment, which can lead to:

  • Increased uptake of best-value biologics1,2
  • Reinvestment of cost savings in the development of new and innovative therapies1
  • Improved patient care1
  • Additional treatment choices for patients and HCPs1

Encouraging innovation 
The development of biosimilars can create a more progressive, competitive environment, encouraging investment in the development of new biologic products.1 This can lead to:

  • Innovation among reference product manufacturers1
  • Increased uptake of best-value biologics1,2
  • Reinvestment of cost savings in the development of new and innovative therapies1

What types of biosimilars do we have in development? Learn here

References:
1. IMS Institute 2016. Delivering on the potential of biosimilar medicines. Accessed June 22, 2020 at: www.medicinesforeurope.com.
2. IMS Health 2016. The impact of biosimilar competition. Accessed June 22, 2020 at: www.medicinesforeurope.com.